Positive context积极背景
Stocks股票 / Health Care / TVTX
Travere Therapeutics Inc · Health Care
TVTX US listed · USD美股 · 美元
Health Care
Russell 2000罗素2000
Speculative / unprofitable投机／未盈利
$49.60
Regular quote常规时段报价
-$3.19 · -6.04%
Extended quote unavailable. Showing the regular quote.盘前盘后报价暂不可用，现显示常规时段报价。
Pre-market盘前
·
52w low52周低 $26.08high高 $68.59
Avoid — downtrend回避 — 下行趋势
Downtrend — stand aside until a new cycle low forms and confirms.下跌趋势——观望，直至新的周期低点形成并确认。
As of 2026-10-26截至 2026-10-26
Company news公司新闻
The latest reporting最新报道
One story, with the reporting behind it.将同一事件汇总，保留各来源报道。
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-10-26
Momentum (RSI 14)动量（RSI 14）
27
Oversold超卖区域
vs 50-day average相对50日均线
-19.2% below下方
Below trend跌破趋势
vs 200-day average相对200日均线
+8.3% above上方
Long trend up长期向上
Volatility波动率
24th percentile第24百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-10-294
Mixed — beat 1 of last 4 quarters表现不稳 — 近 4 季中 1 季超预期
Post-earnings drift: +5.7% (20d)财报后漂移：+5.7%（20日）
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 -1.0%
Financials财务数据
fiscal years财年Revenue营业收入
$490.7M2025
20202025
5-yr growth5年复合增速 19.9%
Earnings per share每股收益
$-0.292025
20202025
Free cash flow自由现金流
-$280.7M2023
20202025
Operating margin营业利润率
-12.8%
Net margin净利率
-5.2%
FCF margin自由现金流利润率
7.7%
Balance-sheet quality财务体质 6/8
Return on equity股本回报率 -22%
Watch关注
Leverage杠杆
Current ratio流动比率2.74
Capital allocation资本配置
Stock-based comp股权薪酬$44.9M
Share count change (1y)股数变化（1年）+4.0%
Debt coming due到期债务
SEC filingsSEC 文件Its filings are available, but they do not break debt down by the year it comes due — every bucket below is unreported.已获取该公司的 SEC 文件，但文件中未按到期年度拆分债务 —— 以下各区间均未披露。
Next 12 months未来12个月
not reported未披露
Year 2第2年
not reported未披露
Year 3第3年
not reported未披露
Year 4第4年
not reported未披露
Year 5第5年
not reported未披露
After year 55年以后
not reported未披露
Not every company reports a year-by-year schedule. Nothing is being estimated in its place.并非所有公司都会披露逐年到期安排；此处不作任何估算替代。
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前，现金流情景暂不可用。
Capital-need coverage is not available for this issuer yet.该发行人的资本需求覆盖信息暂不可用。
Reported facts remain separate from the cash-flow scenario until identity and filing provenance are confirmed.在确认身份与报告来源之前，已披露事实与现金流情景保持分离。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
TVTX RSI reached oversoldTVTX RSI进入超卖
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$83.5M net (0 buyers, 11 sellers)-$83.5M 净值（0 买家，11 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Polen Capital Management | C | New position新建仓 | 0.0% | 2026-06-30 |
| Perceptive Advisors | A | Holding持有 | 3.2% | 2026-06-30 |
| RA Capital Management | D | exitexit | 0.0% | 2026-06-30 |
Signal history信号历史
engine events引擎事件
NEARING A LOW → DOWNTREND接近低点 → 下跌趋势
AVOID. Failed cycle — price broke below the low that started this cycle, which historically means the larger trend is rolling over (~80% of cases)回避。失败周期——价格跌破了启动本周期的低点，历史上这通常意味着更大的趋势正在掉头向下（约 80% 的情形）
Oct 16, 2026
TVTX RSI reached oversoldTVTX RSI进入超卖
RSI(14) crossed below 30 — washed out; context, not a timing trigger alone. $49.60.RSI(14)下穿30 — 超卖；仅作背景，单独不构成择时。$49.60。
Oct 15, 2026
TVTX broke down vs the marketTVTX 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $52.79.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$52.79。
Oct 15, 2026
TVTX StochRSI turned up from oversoldTVTX StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $52.79.StochRSI重回20上方 — 下行动量趋缓的最早预警。$52.79。
Oct 8, 2026
TVTX broke down vs the marketTVTX 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $52.04.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$52.04。
Oct 7, 2026
TVTX RSI reached oversoldTVTX RSI进入超卖
RSI(14) crossed below 30 — washed out; context, not a timing trigger alone. $53.44.RSI(14)下穿30 — 超卖；仅作背景，单独不构成择时。$53.44。
Oct 6, 2026
UNCONFIRMED TURN → NEARING A LOW未确认转向 → 接近低点
GET READY准备
Oct 2, 2026
NEARING A LOW → UNCONFIRMED TURN接近低点 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Sep 30, 2026
UNCONFIRMED TURN → NEARING A LOW未确认转向 → 接近低点
GET READY准备
Showing the last 15 of显示最近15条，共 186 signals条信号
Company profile公司档案
Watch items — what could change the story关注项 — 可能改变故事的因素
- Receivables stretch
- Inventory build
- Capital intensity rising
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -4.8% | -2.0% |
| 1 Month近1月 | -21.9% | +1.5% |
| 3 Months近3月 | -12.5% | +2.9% |
| 6 Months近6月 | +21.7% | +8.0% |
| Year to date年初至今 | +25.5% | +12.6% |
| 1 Year近1年 | +80.3% | +16.8% |
Trading information交易信息
Volatility rank波动率分位
24th pctile
EPS (trailing)每股收益
$-0.28
Off 52-week high距52周高点
-26.5%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $198M | $227M | $212M | $145M | $233M | $491M |
| EPS每股收益 | $-3.56 | $-3.01 | $-4.37 | $-1.50 | $-4.08 | $-0.29 |
| Free cash flow自由现金流 | $-50M | $-20M | $-186M | $-281M | — | — |
| Gross margin毛利率 | 96.9% | 97.0% | 96.4% | 92.1% | 96.7% | 97.9% |
| Net margin净利率 | -85.4% | -79.2% | -131.3% | -76.7% | -137.9% | -5.2% |
| FCF margin自由现金流利润率 | -25.0% | -8.7% | -88.0% | -193.3% | — | — |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$491M
Net income净利润
$-26M
Operating cash flow经营现金流
$38M
Total assets总资产
$605M
Shareholder equity股东权益
$115M
Shares outstanding总股本
0.09B
Returns & growth回报与增长
Return on equity股本回报率
-22.2%
Return on assets资产回报率
-4.2%
Asset growth资产增速
+1.9%
Accounting quality checks会计质量检查
- Earnings quality: accruals trending up over 6 fiscal years — earnings increasingly not cash-backed盈利质量：应计利润在 6 个财年间走高——盈利的现金支撑减弱
- Working capital: inventory +375% vs sales +147%; receivables +403% vs sales +147% — demand & revenue-quality risk营运资本：存货 +375% 对销售 +147%；应收 +403% 对销售 +147%——需求与营收质量风险
- Pricing power: gross margin +1.0pts over 6 years定价能力：毛利率 6 年上升 1.0 个百分点
- Capital discipline: share count +74.0% over 6 years (dilution)资本纪律：股本 6 年增加 74.0%（稀释）
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
27
RSI (2-day)RSI（2日）
10
vs 20-day average相对20日均线
-12.1%
vs 50-day average相对50日均线
-19.2%
vs 200-day average相对200日均线
+8.3%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down动能向下
3-day3日线
momentum down动能向下
Weekly周线
momentum down动能向下
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
74/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $-0.37 | $-0.14 | -164.3% |
| Mar 2026 | $-0.39 | $-0.30 | -30.0% |
| Dec 2025 | $0.03 | $0.03 | 0.0% |
| Sep 2025 | $0.28 | $-0.31 | +190.3% |
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Polen Capital Management | C | New position新建仓 | 0.0% | $2M |
| Perceptive Advisors | A | Holding持有 | 3.2% | $213M |
| RA Capital Management | D | Exited清仓 | 0.0% | $22M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
3
Buying vs selling买入vs卖出
1 : 1
Quarterly trend季度趋势
{'direction': 'accumulating', 'n_quarters': 11, 'holders_first': 1, 'holders_last': 2, 'holders_delta': 1, 'value_change_pct': 3962.2, 'from_period': '2023-09-30', 'to_period': '2026-03-31', 'available_on': '2026-05-16', 'available_on_first': '2023-11-15', 'holders_series': [1, 1, 0, 0, 0, 2, 2, 2, 2, 1, 2]}{'direction': 'accumulating', 'n_quarters': 11, 'holders_first': 1, 'holders_last': 2, 'holders_delta': 1, 'value_change_pct': 3962.2, 'from_period': '2023-09-30', 'to_period': '2026-03-31', 'available_on': '2026-05-16', 'available_on_first': '2023-11-15', 'holders_series': [1, 1, 0, 0, 0, 2, 2, 2, 2, 1, 2]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$83.5M
Insider buyers vs sellers内部人买家vs卖家
0 : 11
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
accumulating持续增持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。